Evidence map›Paper›PMID 38850495›Full record

ReviewArchives of pharmacal research2024

Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review.

Ping Wang, Xiaomei Huang, Chenyuan Jiang, Rushuang Yang, Jialing Wu, Yinghui Liu, Shuangshuang Feng, Tingting Wang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of pharmacal research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ping WangLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Xiaomei HuangDepartment of Marine Biology, Xiamen Ocean Vocational College, Xiamen, 361100, Fujian, China.
Chenyuan JiangLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Rushuang YangLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Jialing WuLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Yinghui LiuLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Shuangshuang FengLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Tingting WangLi Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China. wangtingting1@nbu.edu.cn.

Funding

Key Laboratory of Marine Biological Genetic Resources HY202205National 111 Project of China D16013Zhejiang Province Public Welfare Technology Application Research Project LGF21D060003
6 · The paper itself

Abstract

The oceans are rich in diverse microorganisms, animals, and plants. This vast biological complexity is a major source of unique secondary metabolites. In particular, marine fungi are a promising source of compounds with unique structures and potent antibacterial properties. Over the last decade, substantial progress has been made to identify these valuable antibacterial agents. This review summarizes the chemical structures and antibacterial activities of 223 compounds identified between 2012 and 2023. These compounds, effective against various bacteria including drug-resistant strains such as methicillin-resistant Staphylococcus aureus, exhibit strong potential as antibacterial therapeutics. The review also highlights the relevant challenges in transitioning from drug discovery to product commercialization. Emerging technologies such as metagenomics and synthetic biology are proposed as viable solutions. This paper sets the stage for further research on antibacterial compounds derived from marine fungi and advocates a multidisciplinary approach to combat drug-resistant bacteria.

Indexed as

Anti-Bacterial AgentsBiological ProductsFungiAnimalsAquatic OrganismsBacteriaDrug DiscoveryHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBiological ProductsAntibacterial activityDrug discoveryFungal metabolitesMarine natural products

Identifiers

PMID38850495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.